Table 2.
Colonization of Italian LTCF residents and staff with MRSA and multi-drug resistant Enterobacteriaceae
| Province, year | No. of residents (R), staff (S), LTCFs (L) included | Mean age in years/female % | Specimen types | Residents, colonizationwith MDR (%) | Staff, colonization with MDR (%) | Referencesa |
|---|---|---|---|---|---|---|
| Bergamo, 2005 | R (88), S (51), L (1) | 83/80 | Nasal | MRSA (19.3) | MRSA (5.8) | [39] |
| Vicenza, 2006 | R (551), L (2) | 83/73 | Nasal | MRSA (7.8) | [62] | |
| Various provincesb, 2006 | R (221), L (23) | 83/61 | Catheter urine | ESBL/AmpC (54.0) | [22] | |
| Bolzano, 2008c | R (111), S (69), L (1) | 84/55 | Rectal, inguinal, oro-pharyngeal, nasal, urine | ESBL (64.0) AmpC (4.5) Carbapenemase VIM-1 (6.3) MRSA (38.7) VRE (2.7) |
ESBL (14.5) AmpC (1.5) Carbapenemase VIM (1.5) MRSA (14.5) |
[13] |
| Bolzano, 2012c | R (131), S (57), L (2) | 83/60 | Rectal, inguinal, oro-pharyngeal, nasal, urine | ESBL (49.0) AmpC (2.9) Carbapenemase VIM-1 (1.5) MRSA (13.2) |
ESBL (5.2) AmpC (0.0) Carbapenemase VIM (0.0) MRSA (7.0) |
[14] |
| Various provincesd, 2015 | R (489), L (12) | 85/69 | Rectal, nasal, axillary | ESBL (57.3) Carbapenemase KPC-3/VIM-1 (1.0) MRSA (17.2) | [23] |
aAll studies are point prevalence studies; b 70 % Northern Italy, 5 % Central Italy, 25 % Southern Italy; c one of the LTCFs was screened in 2008 and 2012; carbapenemase screening was done on chromogenic ESBL agar plates; d 50 % Northern Italy, 50 % Central Italy